NCT03442751View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

November 1, 2019

Study Completion Date

August 10, 2020

Conditions
Progressive Keratoconus
Interventions
DRUG

Test Article A

Riboflavin Ophthalmic Solution A

DRUG

Test Article B

Riboflavin Ophthalmic Solution B

DRUG

Placebo

Placebo Vehicle of Test Article

DEVICE

KXL medical device system

Mock UVA light source

DEVICE

KXL medical device system

Cross-linking UVA light source

Trial Locations (1)

02451

Ophthalmic Consultants of Boston, Waltham

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY